|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2010-1-1
|
|
pubmed:abstractText |
The prognosis of recurrent glioblastoma multiforme (GBM) remains unsatisfactory. The authors conducted a Phase II study of ifosfamide, carboplatin, and etoposide (ICE) for a first recurrence of GBM to determine whether it prolonged a patient's good-quality life.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1933-0693
|
|
pubmed:author |
pubmed-author:AokiTomokazuT,
pubmed-author:MatsutaniMasaoM,
pubmed-author:MiyatakeShin-IchiS,
pubmed-author:MizutaniTomohikoT,
pubmed-author:NojimaKuniharuK,
pubmed-author:NozakiKazuhikoK,
pubmed-author:OkumuraRyosukeR,
pubmed-author:TakagiTakehisaT,
pubmed-author:TakahashiJun AJA,
pubmed-author:TakiWaroW,
pubmed-author:UebaTetsuyaT,
pubmed-author:YubaYoshiakiY
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
112
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
50-6
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:19538050-Adult,
pubmed-meshheading:19538050-Aged,
pubmed-meshheading:19538050-Antineoplastic Agents,
pubmed-meshheading:19538050-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19538050-Brain Neoplasms,
pubmed-meshheading:19538050-Carboplatin,
pubmed-meshheading:19538050-Disease Progression,
pubmed-meshheading:19538050-Etoposide,
pubmed-meshheading:19538050-Female,
pubmed-meshheading:19538050-Glioblastoma,
pubmed-meshheading:19538050-Humans,
pubmed-meshheading:19538050-Ifosfamide,
pubmed-meshheading:19538050-Kaplan-Meier Estimate,
pubmed-meshheading:19538050-Male,
pubmed-meshheading:19538050-Middle Aged,
pubmed-meshheading:19538050-Neoplasm Recurrence, Local,
pubmed-meshheading:19538050-Quality of Life,
pubmed-meshheading:19538050-Time Factors,
pubmed-meshheading:19538050-Treatment Outcome,
pubmed-meshheading:19538050-Young Adult
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Phase II study of ifosfamide, carboplatin, and etoposide in patients with a first recurrence of glioblastoma multiforme.
|
|
pubmed:affiliation |
Department of Neurosurgery, Kitano Hospital Medical Research Institute, Osaka, Japan. tomokazu@kitano-hp.or.jp
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
